Mondaq All Regions - Belgium: Food, Drugs, Healthcare, Life Sciences
Hogan Lovells
The default legal position is that the UK will leave the EU automatically at 11pm on 29 March 2019 with no "deal" in place, unless something else is agreed.
Hogan Lovells
Investing in the life sciences industry without an understanding of the key regulatory factors that could determine a product's success or failure could cost you millions of dollars.
Hogan Lovells
Food product labels are under intense scrutiny from consumers, regulators, class action lawyers, and non-governmental organizations (NGOs).
Hogan Lovells
On April 9, 2018, the Centers for Medicare & Medicaid Services (CMS) released the Benefit and Payment Parameters final rule for 2019 (2019 Payment Notice) applicable to qualified health plans (QHPs) ...
Hogan Lovells
On May 11, 2018, President Trump and Department of Health and Human Services (HHS) Secretary Alex Azar delivered highly anticipated speeches regarding the Administration's plan to reduce drug prices.
Van Bael & Bellis
On 27 July 2015, the Minister for Social Affairs and Public Health, Maggie De Block ("the Minister"), and the pharmaceutical sector umbrella organisations pharma.be and FeBelGen entered into a "Pact for the Future"...
Jones Day
The Belgian Food Safety Agency recently provided advice on the microbial and chemical safety of insects intended for human consumption.
Fieldfisher LLP
In Europa zouden al zeven miljoen rokers de klassieke sigaret gedeeltelijk of volledig hebben ingeruild voor haar elektronische tegenhanger.
K&L Gates GP
The Court of Justice of the EU has recently ruled that EU law allows national authorities to provide the public with information identifying a food business operator whose food is unfit for human consumption even though it is not injurious to human health.
NautaDutilh
The medical devices sector covers a wide range of products, from simple bandages to highly sophisticated devices such as pacemakers, as well as contact lenses, prostheses, medical equipment for hospital use, etc.
Steptoe & Johnson LLP
Previous editions of EU Analyst have examined how key decisions on EU environment and life sciences regulation are taken behind closed doors. In the EU legal framework, ‘comitology’ committees (made up of a representative from each EU Member State and chaired by the European Commission) simply implement rules laid down by the Council.
Mayer Brown
On December 5, 2018, the General Court (Court) ruled in favor of the European Commission in a case brought by Bristol-Myers Squibb Pharma (BMS) ...
Hogan Lovells
The 2010 Physician Payments Sunshine Act created a new standard of transparency for financial relationships between pharmaceutical companies and health care professionals in the U.S.
Van Bael & Bellis
Under Article 4 of the Directive, a person injured by a defective product should prove the damage, the defect and the causal relationship between defect and damage.
Van Bael & Bellis
Subject to a few exceptions, EU Member States should apply the national implementing measures of the TPD as from 20 May 2016.
Jones Day
On January 22, 2015, EFSA announced it would make it easier for external observers to attend open plenary meetings by increasing its scientific panels and Scientific Committee open plenary meetings to be held in Brussels.
White & Case
The European Commission's hesitation to provide a legal definition of nanomaterials came to an end last week when its services adopted and released a long-awaited and much-debated recommendation for a regulatory definition for nanomaterials on 18 October.
Van Bael & Bellis
In the midst of the debate over the co-existence of traditional and GM crops, the Court of Justice of the European Union (ECJ) has delivered two very important judgments in the space of a few days.
Howrey LLP
The European Commission has started to consider whether Directive 2001/ 20/EC, better known as the Clinical Trials Directive (the Directive), needs to be revised.
Hogan Lovells
In a significant step towards implementing its American Patients First blueprint for lowering prescription drug prices and patient out-of-pocket costs
Latest Video
Most Popular Recent Articles
Hogan Lovells
Investing in the life sciences industry without an understanding of the key regulatory factors that could determine a product's success or failure could cost you millions of dollars.
Hogan Lovells
The 2010 Physician Payments Sunshine Act created a new standard of transparency for financial relationships between pharmaceutical companies and health care professionals in the U.S.
Hogan Lovells
On May 11, 2018, President Trump and Department of Health and Human Services (HHS) Secretary Alex Azar delivered highly anticipated speeches regarding the Administration's plan to reduce drug prices.
Van Bael & Bellis
Under Article 4 of the Directive, a person injured by a defective product should prove the damage, the defect and the causal relationship between defect and damage.
Hogan Lovells
Food product labels are under intense scrutiny from consumers, regulators, class action lawyers, and non-governmental organizations (NGOs).
Hogan Lovells
On April 9, 2018, the Centers for Medicare & Medicaid Services (CMS) released the Benefit and Payment Parameters final rule for 2019 (2019 Payment Notice) applicable to qualified health plans (QHPs) ...
Article Search Using Filters
Related Topics
Popular Authors
Popular Contributors
Up-coming Events Search
Tools
Font Size:
Translation
Channels
Mondaq on Twitter